Pharmacology
News
FDA approves first drug that protects against chemo-induced myelosuppression
News
Semaglutide for weight loss? A good first STEP, with caveats
“On the face of it, the STEP 1 trial (like its name) is a good beginning,” said the editorialists. More patients in the semaglutide group had...
News
Antidepressants may scupper efficacy of MDMA for PTSD
The findings have implications for clinical practice if MDMA-assisted psychotherapy is approved by the FDA, said Dr. Allison Feduccia.
Conference Coverage
‘Unprecedented’ long-term survival after immunotherapy in pretreated NSCLC
Conference Coverage
Vedolizumab looks safer than anti-TNF drugs in older adults with IBD
An analysis of a Medicare claims database finds vedolizumab is associated with efficacy similar to that of anti-TNF inhibitors, with fewer...
News
Prostate drugs tied to lower risk for Parkinson’s disease
If confirmed by additional trials, glycolysis-enhancing drugs could be a new option to slow progression of Parkinson’s disease,
News
ColCORONA: More questions than answers for colchicine in COVID-19
Millions of dollars and thousands of patients later, the phase 3 study highlights the challenges of COVID-19–related preprint studies without peer...
News
Vaccine may blunt effects of deadly synthetic opioids
The latest data bring “hope that this approach will work to treat a number of opioid-related maladies,” said Dr. Kim Janda.
Conference Coverage
Neoadjuvant immunotherapy shows promise in stage III melanoma
There is both preclinical and clinical evidence that neoadjuvant therapy may offer a survival advantage over adjuvant therapy.
Conference Coverage
COVID-19: Peginterferon lambda may prevent clinical deterioration, shorten viral shedding
Activity against respiratory pathogens has been demonstrated for interferon lambda-1, a type III interferon.